Expand BEAM Menu
BEAM MENU

BEAM Latest Press Releases

-- May 18, 2026 --

Beam Therapeutics Presents Recently Reported Topline Clinical Data for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) at the American Thoracic Society (ATS) 2026 International Conference Globe Newswire 4:00 PM

-- May 13, 2026 --

Beam Therapeutics Supports AlphaDetect to Accelerate Detection of Alpha-1 PRNewswire 11:50 AM
Beam Therapeutics to Present at 2026 RBC Capital Markets Global Healthcare Conference Globe Newswire 7:00 AM

-- May 12, 2026 --

Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel's Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026 Globe Newswire 9:30 AM

-- May 7, 2026 --

Beam Therapeutics Reports First Quarter 2026 Financial Results and Recent Business Updates Globe Newswire 7:00 AM

-- April 1, 2026 --

Beam Therapeutics Announces Publication of BEACON Phase 1/2 Data for risto-cel in Patients with Sickle Cell Disease (SCD) in The New England Journal of Medicine Globe Newswire 5:12 PM

-- March 25, 2026 --

Beam Therapeutics Announces Compelling Updated Clinical Data from the Ongoing Phase 1/2 Trial of BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) to Support Advancement to Pivotal Development Globe Newswire 7:00 AM

-- February 24, 2026 --

Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU) Globe Newswire 7:01 AM
Beam Therapeutics Announces $500 Million Strategic Financing Facility with Sixth Street Globe Newswire 7:00 AM

-- February 23, 2026 --

Beam Therapeutics to Host Investor Webcast for Fourth Quarter and Year-End 2025 Financial Results and New Liver-targeted Genetic Disease Program Globe Newswire 4:00 PM

-- January 11, 2026 --

Beam Therapeutics Sets Strategic Priorities for its Genetic Disease and Hematology Franchises to Drive Execution of Late-Stage Clinical Programs and Extends its Operating Runway through Commercial Transition Globe Newswire 5:00 PM
Market Data Delayed 15 Minutes